NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals.

NICE has announced today, its decision not to recommend olaparib for women with advanced ovarian cancer who had previously responded to platinum chemotherapy for six months or longer.

In its 12th year raising money for The Institute of Cancer Research, London, the Climb of Life has reached the tremendous milestone of raising over £1 million.